According to the agreement, Vindur Tx will pay Optic up to $17.5 million for its proprietary technology to explore new ways of addressing previously "undruggable" targets in difficult-to-treat cancers ...

Once identified, a long/short manager will buy the stronger-performing company in the pair and sell the weaker-performing ...